newsfilter
← Latest News
GlobeNewswire·

argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

April 30, 2026Amsterdam, the Netherlands – argenx ((Euronext &, NASDAQ:ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it